- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01358890
Low-Carbohydrate Diet Intervention on Body Weight
Effect of Low-Carbohydrate or Restricted-Calories Diet on Body Weight
- The primary aim of this study is to determine the adherence of low- carbohydrate among Chinese.
- Then compare the effect of low-carbohydrate and traditional Chinese but restricted-calories diet on weight loss and metabolic traits.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obesity is a well established risk factor for type 2 diabetes mellitus, hypertension, dyslipidemia and cardiovascular disease. Along with rapid nutritional and lifestyle transition featured as increased energy dense diet intake and reduced physical activity, the prevalence of obesity has reached epidemic level and affected more than 70 million Chinese adults nowadays. Previous studies suggested that low-carbohydrate diet was an effective and safe way to lose weight and had potential benefit on lipids profiles. However, it is still unknown whether this diet can be feasible to control the epidemic of obesity and its related metabolic diseases among Chinese, whose carbohydrate consumption contribute approximately 55% of total energy intake.
Therefore, the aim of this pilot study is to investigate the adherence and effectiveness of two weight-loss diets among Chinese. This will be a randomized, controlled clinical trial. A total of 50 overweight or obese nurse assistants will be randomly assigned to receive a low-carbohydrate diet or a traditional high-carbohydrate Chinese but restricted-calories diet for 12 weeks. The adherence of study protocol and effects of the two diets on body weight, waist circumference, body fat, fasting glucose and lipid profile will be evaluated.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200031
- Institute for Nutritional Sciences, Chinese Academy of Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- overweight/obese (BMI ≥24 kg/m2)
Exclusion Criteria:
- Pregnancy or lactation;
- Serum creatinine and blood urea nitrogen level beyond the clinical reference value;
- alanine aminotransferase and aspartate aminotransferase beyond the reference levels;
- Gastrointestinal problems that would prevent them from complying with the specified feeding conditions;
- Received gastrointestinal surgery (except for appendicitis or hernia);
- Severer CVD;
- Active cancer;
- Mental diseases, epilepsia or using anti-depression drugs;
- Participating in other scientific studies within 3 months before the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: B
Subjects will be supplied with low carbohydrate diet for 12 weeks.
|
Dietary carbohydrate diet was restricted to 20 gram/day within the first week, then increase gradually to 120 gram/day
|
|
EXPERIMENTAL: A
Subjects will be supplied with calories restricted diet for 12 weeks
|
Total energy intake is restricted to 1200 kcal/day for women.
Energy from carbohydrate, protein and fat will be kept to approximate 55%, 20% and 25%, respectively.
Moreover, saturated fat and dietary cholesterol are restricted to at most 10% energy and 300 mg/day, respectively
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
weight
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
waist circumference
Time Frame: 12 weeks
|
12 weeks
|
|
LDL-C
Time Frame: 12 weeks
|
12 weeks
|
|
HDL-C
Time Frame: 12 weeks
|
12 weeks
|
|
blood pressure
Time Frame: 12 weeks
|
12 weeks
|
|
body fat mass
Time Frame: 12 weeks
|
12 weeks
|
|
body mass index
Time Frame: 12 weeks
|
12 weeks
|
|
fast glucose
Time Frame: 12 weeks
|
12 weeks
|
|
total cholesterol
Time Frame: 12 weeks
|
12 weeks
|
|
triglyceride
Time Frame: 12 weeks
|
12 weeks
|
|
urinary ketone
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 30930081/C150502-LC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on low carbohydrate diet
-
Uppsala UniversityCompleted
-
University of SurreyBritish Heart FoundationCompleted
-
University Hospital, MotolCzech Academy of SciencesActive, not recruiting
-
Baylor UniversityCompleted
-
University of British ColumbiaMedtronicCompleted
-
Brigham and Women's HospitalBoston Children's Hospital; Boston Medical Center; Nutrition Science Initiative; New Balance Foundation and other collaboratorsCompleted
-
UCSF Benioff Children's Hospital OaklandNational Cattlemen's Beef AssociationCompletedHealthy | Cardiovascular Disease | Atherogenic DyslipidemiaUnited States
-
Haukeland University HospitalUniversity of BergenCompleted
-
Vårdcentralen LyckornaCompleted
-
Hvidovre University HospitalCompletedType 1 DiabetesDenmark